Biologic Outsourcing STREAM

1. Discovering A Unique Multimillion Euro Nanotechnology Facility 10/25/2024

   Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.

2. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

   Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

3. Providing Value Optimized, Time Saving Oligo Solutions 12/16/2021

   Whether you are in the beginning research stages or ready to take your product to market, our scalable, high quality, and custom oligo and peptide solutions provide the quantities you need using the most reliable, robust, and cost-effective process available.

4. Abzena Capacity Update October 2024: ADC 10/21/2024

   Leverage our integrated CRO and CDMO services for the development and manufacturing of complex biologics, bioconjugates, and ADCs, ensuring high-quality products and data packages that meet regulatory requirements.

5. Delivering Therapies To Patients At Scale And At Speed 10/13/2021

   Resilience is addressing a defining challenge: Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.

6. Meeting Needs And Exceeding Expectations Worldwide 10/16/2024

   Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.

7. Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service 11/17/2021

   The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.

8. Rising To Meet Increasing Demand For Microbial Based Biologics 12/16/2021

   The production of your biotherapeutic deserves the reliability and peace of mind that only a trusted and experienced microbial fermentation partner can provide. Ajinomoto Bio-Pharma Services is a recognized leader in recombinant protein, plasmid DNA, and critical raw material manufacturing for vaccine and gene therapy applications.

9. Expertise In Commercial Fill-Finish For More Than 30 Years 8/5/2024

   Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

10. OPTIMA 7000 Fill Line 6/7/2021

    Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.